30098604|t|K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-kappaB-mediated CHI3L1 expression.
30098604|a|BACKGROUND: Alzheimer's disease, which is pathologically characterized by an excessive accumulation of amyloid beta (Abeta) fibrils, is a degenerative brain disease and the most common cause of dementia. In a previous study, it was reported that an increased level of CHI3L1 in plasma was found in AD patients. We investigated the inhibitory effect of 2-({3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinyl}sulfanyl)-N-(4-ethylphenyl)butanamide (K284-6111), an inhibitor of chitinase 3 like 1 (CHI3L1), on memory impairment in Abeta1-42-infused mice, and microglial BV-2 cells and astrocytes. METHODS: We examined whether K284-6111 (3 mg/kg given orally for 4 weeks) prevents amyloidogenesis and memory loss in Abeta1-42-induced AD mice model. After intracerebroventrical (ICV) infusion of Abeta1-42 for 14 days, the cognitive function was assessed by the Morris water maze test and passive avoidance test. K284-6111 treatment was found to reduce Abeta1-42-induced memory loss. RESULTS: A memory recovery effect was found to be associated with the reduction of Abeta1-42-induced expression of inflammatory proteins (iNOS, COX-2, GFAP, and Iba-1) and the suppression of CHI3L1 expression in the brain. Additionally, K284-6111 reduced Abeta1-42-induced beta-secretase activity and Abeta generation. Lipopolysaccharide (LPS)-induced (1 mug/mL) expression of inflammatory (COX-2, iNOS, GFAP, Iba-1) and amyloidogenic proteins (APP, BACE1) were decreased in microglial BV-2 cells and cultured astrocytes by the K284-6111 treatment (0.5, 1, and 2 muM). Moreover, K284-6111 treatment suppressed p50 and p65 translocation into the nucleus, and phosphorylation of IkappaB in vivo and in vitro. CONCLUSION: These results suggest that CHI3L1 inhibitor could be an applicable intervention drug in amyloidogenesis and neuroinflammation, thereby preventing memory dysfunction via inhibition of NF-kappaB.
30098604	0	9	K284-6111	Chemical	MESH:C000712988
30098604	23	35	amyloid beta	Gene	351
30098604	44	61	neuroinflammation	Disease	MESH:D000090862
30098604	66	98	impairment of recognition memory	Disease	MESH:D008569
30098604	121	130	NF-kappaB	Gene	18033
30098604	140	146	CHI3L1	Gene	12654
30098604	171	190	Alzheimer's disease	Disease	MESH:D000544
30098604	262	274	amyloid beta	Gene	351
30098604	276	281	Abeta	Gene	351
30098604	297	323	degenerative brain disease	Disease	MESH:D019636
30098604	353	361	dementia	Disease	MESH:D003704
30098604	427	433	CHI3L1	Gene	1116
30098604	457	459	AD	Disease	MESH:D000544
30098604	460	468	patients	Species	9606
30098604	632	641	K284-6111	Chemical	MESH:C000712988
30098604	660	678	chitinase 3 like 1	Gene	12654
30098604	680	686	CHI3L1	Gene	12654
30098604	692	709	memory impairment	Disease	MESH:D008569
30098604	731	735	mice	Species	10090
30098604	752	756	BV-2	CellLine	CVCL:0182
30098604	808	817	K284-6111	Chemical	MESH:C000712988
30098604	862	877	amyloidogenesis	Disease	
30098604	882	893	memory loss	Disease	MESH:D008569
30098604	915	917	AD	Disease	MESH:D000544
30098604	918	922	mice	Species	10090
30098604	1093	1102	K284-6111	Chemical	MESH:C000712988
30098604	1151	1162	memory loss	Disease	MESH:D008569
30098604	1279	1291	inflammatory	Disease	MESH:D007249
30098604	1302	1306	iNOS	Gene	18126
30098604	1308	1313	COX-2	Gene	17709
30098604	1315	1319	GFAP	Gene	14580
30098604	1325	1330	Iba-1	Gene	114737
30098604	1355	1361	CHI3L1	Gene	12654
30098604	1401	1410	K284-6111	Chemical	MESH:C000712988
30098604	1465	1470	Abeta	Gene	11820
30098604	1483	1501	Lipopolysaccharide	Chemical	MESH:D008070
30098604	1503	1506	LPS	Chemical	MESH:D008070
30098604	1541	1553	inflammatory	Disease	MESH:D007249
30098604	1555	1560	COX-2	Gene	17709
30098604	1562	1566	iNOS	Gene	18126
30098604	1568	1572	GFAP	Gene	14580
30098604	1574	1579	Iba-1	Gene	114737
30098604	1614	1619	BACE1	Gene	23821
30098604	1650	1654	BV-2	CellLine	CVCL:0182
30098604	1692	1701	K284-6111	Chemical	MESH:C000712988
30098604	1743	1752	K284-6111	Chemical	MESH:C000712988
30098604	1774	1777	p50	Gene	18033
30098604	1782	1785	p65	Gene	19697
30098604	1910	1916	CHI3L1	Gene	12654
30098604	1971	1986	amyloidogenesis	Disease	
30098604	1991	2008	neuroinflammation	Disease	MESH:D000090862
30098604	2029	2047	memory dysfunction	Disease	MESH:D008569
30098604	2066	2075	NF-kappaB	Gene	18033
30098604	Positive_Correlation	MESH:D000544	1116
30098604	Negative_Correlation	MESH:C000712988	MESH:D000090862
30098604	Negative_Correlation	MESH:C000712988	11820
30098604	Positive_Correlation	MESH:D008070	17709
30098604	Positive_Correlation	MESH:D008070	18126
30098604	Positive_Correlation	MESH:D008070	14580
30098604	Positive_Correlation	MESH:D008070	23821
30098604	Positive_Correlation	MESH:D000090862	351
30098604	Negative_Correlation	MESH:C000712988	23821
30098604	Negative_Correlation	MESH:C000712988	17709
30098604	Negative_Correlation	MESH:C000712988	18126
30098604	Association	MESH:D008569	351
30098604	Positive_Correlation	MESH:D008070	MESH:D007249
30098604	Negative_Correlation	MESH:C000712988	MESH:D007249
30098604	Negative_Correlation	MESH:C000712988	12654
30098604	Negative_Correlation	MESH:C000712988	MESH:D008070
30098604	Association	MESH:D007249	114737
30098604	Association	MESH:D007249	14580
30098604	Association	MESH:D000544	351
30098604	Association	12654	18033
30098604	Negative_Correlation	MESH:C000712988	MESH:D008569
30098604	Negative_Correlation	MESH:C000712988	114737
30098604	Association	MESH:D007249	17709
30098604	Association	MESH:D008569	18033
30098604	Negative_Correlation	MESH:C000712988	351
30098604	Positive_Correlation	MESH:D008070	114737
30098604	Negative_Correlation	MESH:C000712988	18033
30098604	Negative_Correlation	MESH:C000712988	14580
30098604	Association	MESH:D008569	12654

